Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Union Bancaire Privée increases assets under management by 10%

Friday, January 24, 2014
Opalesque Industry Update -
  • Union Bancaire Privée, UBP SA (UBP) has announced a 10% year-on-year rise in its assets under management to CHF 87.7 billion (USD 98.6 billion) as at 31 December 2013 (CHF 80 billion at the end of 2012).
  • The Group’s operating profit came to CHF 218.3 million (USD 245.5 million), up more than 20% on the previous year, attesting to the business’ good health. UBP’s consolidated net profit came to CHF 152 million (USD 171 million) after provisions (compared with CHF 175 million at the end of 2012).
  • The increase in the operating result is attributable to net inflows of funds from private and institutional clients, as well as to sound asset management performances and to the effects of the post-acquisition synergies.
  • The Bank’s financial base is sound, with a Tier 1 ratio of 29%, making it one of the best-capitalised Swiss banks.

“In the midst of the industry’s mutations and consolidations, UBP can rely on its sound client-acquisition strategy, its high-performance range of products and efficient services, and its teams’ unwavering efforts to meet all its clients’ needs”, says Guy de Picciotto, UBP’s CEO.

Increasing assets and improving results

The Bank expanded its assets under management and increased its operational results in 2013. Assets under management amounted to CHF 87.7 billion as at 31 December 2013, up 10% on the previous year. The Group’s operating profit grew by 20%, to CHF 218.3 million, up from CHF 181.4 million the year before. UBP’s consolidated net profit came to CHF 152 million after provisions (13% lower than the CHF 175 million at the end of 2012). The operational integration of Lloyds having become effective on 1 November 2013, the synergies will come into effect over the first half of 2014.

The year’s income was CHF 694 million (USD 780 million), up from CHF 691 million a year earlier, with a CHF 14 million (9%) fall in the interest margin, offset by a CHF 25.5 million (6%) rise over the year in commissions to CHF 460.6 million (USD 517.9 million). The synergies following the earlier acquisitions reduced operating expenses by 6.6%, to CHF 475.4 million (USD 534.6 million), year on year. The Group’s consolidated cost/income ratio is 68.5%, confirming the Group’s profitability.

UBP

Press release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und